Cargando…

NRF2: The key to tumor- and patient-dependent chemosensitivity in biliary tract cancer?

Detalles Bibliográficos
Autores principales:	Kiesslich, Tobias, Mayr, Christian, Neureiter, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945204/ https://www.ncbi.nlm.nih.gov/pubmed/31648982 http://dx.doi.org/10.1016/j.ebiom.2019.09.046

Ejemplares similares

Biliary tract cancer stem cells - translational options and challenges
por: Mayr, Christian, et al.
Publicado: (2017)

Deregulated MicroRNAs in Biliary Tract Cancer: Functional Targets and Potential Biomarkers
por: Mayr, Christian, et al.
Publicado: (2016)

Editorial: Novel therapeutic approaches for biliary tract cancer and hepatocellular carcinoma
por: Bekric, Dino, et al.
Publicado: (2023)

Long Non-Coding RNAs in Biliary Tract Cancer—An Up-to-Date Review
por: Bekric, Dino, et al.
Publicado: (2020)

Ouabain at nanomolar concentrations is cytotoxic for biliary tract cancer cells
por: Mayr, Christian, et al.
Publicado: (2023)

MicroRNAs Associated with the Efficacy of Photodynamic Therapy in Biliary Tract Cancer Cell Lines
por: Wagner, Andrej, et al.
Publicado: (2014)

Evaluation of Tazemetostat as a Therapeutically Relevant Substance in Biliary Tract Cancer
por: Bekric, Dino, et al.
Publicado: (2023)

The Cancer Stem Cell Inhibitor Napabucasin (BBI608) Shows General Cytotoxicity in Biliary Tract Cancer Cells and Reduces Cancer Stem Cell Characteristics
por: Beyreis, Marlena, et al.
Publicado: (2019)

The green tea catechin epigallocatechin gallate induces cell cycle arrest and shows potential synergism with cisplatin in biliary tract cancer cells
por: Mayr, Christian, et al.
Publicado: (2015)

The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells
por: Mayr, Christian, et al.
Publicado: (2015)

HDAC Screening Identifies the HDAC Class I Inhibitor Romidepsin as a Promising Epigenetic Drug for Biliary Tract Cancer
por: Mayr, Christian, et al.
Publicado: (2021)

Influence of Five Potential Anticancer Drugs on Wnt Pathway and Cell Survival in Human Biliary Tract Cancer Cells
por: WACHTER, Julia, et al.
Publicado: (2011)

Variants in oxidative stress-related genes affect the chemosensitivity through Nrf2-mediated signaling pathway in biliary tract cancer
por: Zhan, Ming, et al.
Publicado: (2019)

Relevance of MicroRNA200 Family and MicroRNA205 for Epithelial to Mesenchymal Transition and Clinical Outcome in Biliary Tract Cancer Patients
por: Urbas, Romana, et al.
Publicado: (2016)

Immunmodulatory Treatment Strategies of Hepatocellular Carcinoma: From Checkpoint Inhibitors Now to an Integrated Approach in the Future
por: Ocker, Matthias, et al.
Publicado: (2021)

Can We Efficiently Target HDAC in Cancer?
por: Kiesslich, Tobias, et al.
Publicado: (2022)

Pancreatic cancer in young adults: changes, challenges, and solutions
por: Primavesi, Florian, et al.
Publicado: (2019)

Dual HER2 Blockade: An Emerging Option in Metastatic Biliary Tract Cancer?
por: Ricci, Angela Dalia, et al.
Publicado: (2021)

MiR-200c-3p Modulates Cisplatin Resistance in Biliary Tract Cancer by ZEB1-Independent Mechanisms
por: Posch, Florian, et al.
Publicado: (2021)

Ferroptosis in Hepatocellular Carcinoma: Mechanisms, Drug Targets and Approaches to Clinical Translation
por: Bekric, Dino, et al.
Publicado: (2022)

The Crosstalk of miRNA and Oxidative Stress in the Liver: From Physiology to Pathology and Clinical Implications
por: Klieser, Eckhard, et al.
Publicado: (2019)

Low VDAC1 Expression Is Associated with an Aggressive Phenotype and Reduced Overall Patient Survival in Cholangiocellular Carcinoma
por: Feichtinger, René Günther, et al.
Publicado: (2019)

Cyclin C: A new responser for chemosensitivity in cancer
por: Fang, Shuai, et al.
Publicado: (2022)

HDAC-Linked “Proliferative” miRNA Expression Pattern in Pancreatic Neuroendocrine Tumors
por: Klieser, Eckhard, et al.
Publicado: (2018)

2-Hydroxylated fatty acids as candidates of novel drugs to promote chemosensitivity of gastric cancer
por: Tsuboi, Kazuhito
Publicado: (2019)

Miniaturization of the Clonogenic Assay Using Confluence Measurement
por: Mayr, Christian, et al.
Publicado: (2018)

Pharmacological Inhibition of Class IIA HDACs by LMK-235 in Pancreatic Neuroendocrine Tumor Cells
por: Wanek, Julia, et al.
Publicado: (2018)

GERD—Barrett—Adenocarcinoma: Do We Have Suitable Prognostic and Predictive Molecular Markers?
por: Illig, Romana, et al.
Publicado: (2013)

Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets
por: Neureiter, Daniel, et al.
Publicado: (2019)

New method for real-time visualization and quantitative characterization of early colorectal cancer in endoscopy: a pilot study
por: Wagner, Andrej, et al.
Publicado: (2022)

Chemosensitivity depends on the dependency
por: Short, Ben
Publicado: (2009)

Robust linear regression model of Ki-67 for mitotic rate in gastrointestinal stromal tumors
por: KEMMERLING, RALF, et al.
Publicado: (2014)

Continuous, label-free, 96-well-based determination of cell migration using confluence measurement
por: Mayr, Christian, et al.
Publicado: (2018)

Luteolin Inhibits Breast Cancer Stemness and Enhances Chemosensitivity through the Nrf2-Mediated Pathway
por: Tsai, Kuen-Jang, et al.
Publicado: (2021)

Brucein D augments the chemosensitivity of gemcitabine in pancreatic cancer via inhibiting the Nrf2 pathway
por: Zhang, Juan, et al.
Publicado: (2022)

Rare Collision Tumor of the Biliary Tract
por: Millien, Valentine Ongeri, et al.
Publicado: (2018)

Tumor growth effects of rapamycin on human biliary tract cancer cells
por: Heuer, Matthias, et al.
Publicado: (2012)

The potential predictive value of tumor budding for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer
por: Jäger, Tarkan, et al.
Publicado: (2018)

Myelodysplastic Syndrome and Histone Deacetylase Inhibitors: “To Be or Not to Be Acetylated”?
por: Stintzing, Sebastian, et al.
Publicado: (2011)

Feasibility of Kahoot! as a Real-Time Assessment Tool in (Histo-)pathology Classroom Teaching
por: Neureiter, Daniel, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_53scjvoooqjpqrdf5knbt8ikl5